You do not have the latest flash plugin or you have disabled javascript.

Finally, the Zyprexa warning label is updated

October 18th, 2007 by Todd Hageman

Pharmalot reports that Eli Lilly is updating the Zyprexa label to include warnings for weight gain, elevated cholesterol and hyperglycemia. 

Thousands of lawsuits accusing the drug maker of improperly marketing Zyprexa and not properly informing patients of these side effects have been filed. What’s more, Eli Lilly is seeking FDA approval to market the antipsychotic drug to teenagers.

If you or someone you know has been injured as a result of a dangerous medication, please contact Todd Hageman toll free at 1-877-767-3108 or email THageman@simonpassanante.com

 

Simon Passanante is nationally recognized as a result of its successful handling of jury trials on a wide variety of cases. You are invited to view the firm’s notable verdicts and settlements. Much of the information on this site is presented through videos. Other pages of this site concern Simon Passanante’s honors and awards, testimonials from clients and referring attorneys, and safety information. Our employee directory is here. If you have any questions for us, email us. See this page for important legal disclosures and to learn about contingent fees. For updates regarding Simon Passanante, we invite you to explore our law blogs.

Simon Passanante PC

701 Market Street

Suite 1450

St. Louis, Missouri 63101

314.241.2929

Toll Free: 877.767.3108

Close
E-mail It